Current Trends in Influenza in the 21st Century 

"Closed due to capacity"

"The Role of LMWH’s in the Clinical Setting"
Speakers Brian K. Plowman, Pharm.D., MBA, BCPS
Location

Flemings Prime Steakhouse and Wine Bar
(Hyatt Regency La Jolla at Aventine)

Map
Date April 17th, 2001
6:30-7:00PM - Registration & Dinner
7:00-8:30PM - Program
8:30-8:45PM - Questions & Answers, Certificates
Goals

To provide the participant with an overview of the current clinical and therapeutic options of Low Molecular Weight Heparin’s (LMWH) in the clinical setting and discuss appropriate risk stratification for usage in thromboembolism and acute coronary syndromes.
Objectives
  1. Understand the basic mechanisms of the thrombotic process and thrombogenesis.
  2. Discuss the clinically pertinent differences between heparin and LMWH, and the differences among the LMWH class.

  3. Briefly discuss the different prophylaxis strategies in patients at risk for venous thromboembolic disease.

  4. Discuss current treatment strategies for the treatment of venous thromboembolism.

  5. Discuss the use of antithrombotic therapy in patients with acute coronary syndromes. 

  6. Discuss the current uses and role of LMWH’s in interventional procedures, such as coronary stent deployment.
Registration Information

Pre-Registration: (please submit by April 10, 2001)

  • FREE - members of SDCPhA, SDSHP
  • Students & Technicians (capacity already met)
  • $10.00 - non-members

On Site Registration:  None

Registration Closed Due to Capacity

First Name *
Last Name*
 Title*
Work
Position
Work Phone
Home Phone
FAX
E-mail*
Affiliation*
Message

* Required

For more info:  John Johnson, PharmD - SDCPhA/SDSHP CE Coordinator, VM.  760-875-7709, email:  education@sdcpha.com, PO Box 83834, San Diego, CA 92138, FAX  760-875-7709
Program Supported by Aventis Pharmaceuticals